Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...

By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...